MedTrace Logo

Evaluation of a New Communication Aid Tool to Favor Global Patient Centered Care

NCT04179695 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2025-12-23

No results posted yet for this study

Summary

PARKINSUN is a new communication aid tool, expected to favor global patient centered care for PD patients during consultation with GPs and neurologists. Two groups of patients will be randomized to use or not PARKINSUN when they consult their physicians every 3 months during 7 months.

Conditions

Interventions

OTHER

Consulting with PARKINSUN as communication aid-tool

Participating patients visit their general practitioner or neurologist with PARKINSUN at 1 months, 4 months, 7 months

OTHER

Consulting without PARKINSUN as communication aid-tool

Participating patients visit their general practitioner or neurologist without PARKINSUN at 1 months, 4 months, 7 months

Sponsors & Collaborators

  • Expert center of Parkinson's Disease (CHU Lille)

    collaborator UNKNOWN

  • College of teaching general practitioners (CEMG Lille)

    collaborator UNKNOWN

  • Regional Health Agency (ARS)

    collaborator UNKNOWN

  • UCB Pharma

    collaborator INDUSTRY

  • Orkyn'

    collaborator INDUSTRY

  • University Hospital, Lille

    lead OTHER

Principal Investigators

  • David Devos · University Hospital, Lille

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-21
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04179695 on ClinicalTrials.gov